Portola Pharmaceuticals, LLC

CA · United States · Reporting entity ID 100000246827

Total reported 2019–2025

$8.84M

#532 of 2,960 reporting companies — 0% of all reported industry payments

$3.02M in general payments across 12,758 records, plus $5.82M in research funding across 1,318 records.

How it breaks down

General payments $3,022,928

Research funding $5,815,114

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.